| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/15/1994 | WO1994020107A1 Rejection inhibitor for transplants and il-1 production inhibitor |
| 09/15/1994 | WO1994020099A1 3,4-diarylchromans for treatment of dermatitis |
| 09/15/1994 | WO1994020093A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
| 09/15/1994 | WO1994020083A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | WO1994020062A2 Balanoids as protein kinase c inhibitors |
| 09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
| 09/15/1994 | WO1994016723A3 Wound healing composition |
| 09/15/1994 | WO1994015598A3 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 09/15/1994 | WO1994011010A3 Compositions of oak bark extract, related synthetic compositions, and method of using same |
| 09/15/1994 | CA2157901A1 Bone stimulating factor |
| 09/15/1994 | CA2157865A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | CA2157798A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 09/15/1994 | CA2157782A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | CA2157580A1 Heterocyclic compounds and their preparation and use |
| 09/15/1994 | CA2157412A1 Balanoids |
| 09/15/1994 | CA2156410A1 Pyrrolo-pyridine derivatives |
| 09/15/1994 | CA2153951A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-one-1,1-dioxide derivatives as non- competitive nmda receptor antagonists |
| 09/15/1994 | CA2134880A1 Graft rejection inhibitor and il-1 production inhibitor |
| 09/14/1994 | EP0614984A2 Human anti-TNF antibodies |
| 09/14/1994 | EP0614979A1 Hog cholera virus vaccine and diagnostic |
| 09/14/1994 | EP0614975A1 Glycoprotein hormone receptor molecules |
| 09/14/1994 | EP0614974A2 Bone - associated transcription control factor-like protein and process for producing the same |
| 09/14/1994 | EP0614896A1 Esculetin derivatives and pharmaceutical composition |
| 09/14/1994 | EP0614662A1 Use of (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid for the treatment of leukaemia |
| 09/14/1994 | EP0614661A2 Benzylidene- and cinnamylidine-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells |
| 09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 09/14/1994 | EP0614489A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/14/1994 | EP0614369A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 09/14/1994 | EP0489032B1 Hydroxamic acid based collagenase inhibitors |
| 09/14/1994 | CN1092076A Targeted delivery of growth factors for bone regeneration |
| 09/14/1994 | CN1092071A Spiro piperidines and homologs which promote release of growth hormone |
| 09/14/1994 | CN1092067A Quinazoline derivatives and their preparation |
| 09/14/1994 | CN1092059A Substituted benzoic acids |
| 09/14/1994 | CN1091955A Hematopoietic facilitatory cells |
| 09/13/1994 | US5347036 Substituted di-t-butylphenols |
| 09/13/1994 | US5347013 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles |
| 09/13/1994 | US5347011 Substituted triazoles as angiotensin II inhibitors |
| 09/13/1994 | US5346915 Chromans and thiochromans with phenylethynyl substituents at the 7-position having retinold-like biological activity |
| 09/13/1994 | US5346896 1-(aryl or heteroaryl)-4[ω-(aryl or heteroaryl)ω-(aryl or heteroaryl)alkylene]piperazines |
| 09/13/1994 | US5346894 Treatment of lyso PAF-mediated diseases with PAF antagonists and procedure for determining their efficacy |
| 09/13/1994 | US5346886 For increasing chemical stability and penetration of protease inhibitor in the skin |
| 09/13/1994 | US5346697 Active oxygen scavenger |
| 09/13/1994 | CA2118876A1 2,4-diamino-3-hydroxycarboxylic acid derivatives |
| 09/13/1994 | CA1331992C Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances |
| 09/12/1994 | CA2117116A1 Cell differentiation inducer comprising acyclic polyisoprenoid |
| 09/11/1994 | CA2118642A1 Bone-associated transcription control factor-like protein and process for producing the same |
| 09/07/1994 | EP0613898A1 Aryl or arylalkyl-carbonyl heterocyclic derivatives, processes for their preparation and compositions containing them |
| 09/07/1994 | EP0613897A1 Piperidine derivatives with antihistaminic and antileukotriene activity |
| 09/07/1994 | EP0613894A1 N-Heteroaryl-N'-phenylurea derivatives, their production and use |
| 09/07/1994 | EP0613883A1 Hydroxamic acid derivative |
| 09/07/1994 | EP0613684A1 Solid form xerostomia product |
| 09/07/1994 | EP0613499A1 Human il-4 mutant proteins |
| 09/07/1994 | EP0613476A1 3-pyridinol derivatives and their use as medicaments |
| 09/07/1994 | EP0613472A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| 09/07/1994 | EP0613467A1 2-pyridinol derivatives and their use as medicaments |
| 09/07/1994 | EP0613465A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 09/07/1994 | EP0613463A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation |
| 09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 09/07/1994 | EP0613373A1 Risedronate delayed-release compositions |
| 09/07/1994 | EP0563127B1 Improved treatment method for cancer |
| 09/07/1994 | CN1091742A 水溶性喜树碱衍生物 Water-soluble derivative of camptothecin |
| 09/07/1994 | CN1091741A Tartronic acids, their acetalic ethers and o-esters |
| 09/07/1994 | CN1091733A Anti-androgenic cyclo and bicyclo alkenes |
| 09/07/1994 | CN1091636A Medicaments |
| 09/07/1994 | CN1091634A Stabilized pharmaceutical compositions comprising an HMG-conreductase inhibitor compound |
| 09/07/1994 | CN1091632A Medicaments |
| 09/07/1994 | CN1025855C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| 09/07/1994 | CN1025854C Novel quinolyloxazole-2-ones useful as proteinkinase c inhibitors |
| 09/07/1994 | CN1025853C Antithromotic compounds |
| 09/06/1994 | US5344991 Sulfonyl or sulfamyl derivatives for treatment of arthritis and pain |
| 09/06/1994 | US5344937 Alkyl substituted nitroimidazole acetic acids |
| 09/06/1994 | US5344929 Preparation of carbonic anhydrase inhibitors |
| 09/06/1994 | US5344915 Proteins and the preparation thereof |
| 09/06/1994 | US5344842 Thiosemicarbazone derivatives |
| 09/06/1994 | US5344841 Bis-(hydroxylakylamino)-anthraquinone inhibitors of protein kinase C |
| 09/06/1994 | US5344828 Piperazinealkanoic acid and a pharmaceutical composition comprising the same |
| 09/06/1994 | US5344654 Protein coating |
| 09/06/1994 | CA2116881A1 (aryl(alkyl)carbonyl) heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 09/01/1994 | WO1994019462A1 Harp family growth factors, preparation methods therefor and uses thereof |
| 09/01/1994 | WO1994019350A1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 09/01/1994 | WO1994019344A1 Amide compounds with pharmacological activity |
| 09/01/1994 | WO1994019335A1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 09/01/1994 | WO1994019332A1 Retroviral protease inhibiting compounds |
| 09/01/1994 | WO1994019330A1 Heterocyclic-substituted alkyl amide acat inhibitors |
| 09/01/1994 | WO1994019329A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 09/01/1994 | WO1994019325A1 Coupling product obtained from hystamine and an amino acid |
| 09/01/1994 | WO1994019323A1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists |
| 09/01/1994 | WO1994019316A1 New compounds |
| 09/01/1994 | WO1994019315A1 New compounds |
| 09/01/1994 | WO1994019311A1 Polyamine derivatives as radioprotective agents |
| 09/01/1994 | WO1994019016A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/01/1994 | WO1994018990A1 Combination cisplatin/tamoxifen therapy for human cancers |
| 09/01/1994 | WO1994018985A1 USE OF 26,26,26,27,27,27-HEXAFLUORO-1α,25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS |
| 09/01/1994 | WO1994018983A1 Hormone replacement therapy |
| 09/01/1994 | WO1994018973A1 Bisacodyl dosage form |
| 09/01/1994 | WO1994018968A1 Methods for treating arteriosclerosis |
| 09/01/1994 | WO1994018964A1 USE OF φ-GUANIDINOCARBOXYLIC ACID ESTERS |
| 09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |